Clinical Trial Detail

NCT ID NCT02305758
Title Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Fluorouracil + Irinotecan + Leucovorin

Bevacizumab

Veliparib

Age Groups: adult

No variant requirements are available.